Optimizing an insulin prescription is one of the most vexing challenges facing a busy primary care physician. Our latest enhancement to the ALRT remote monitoring system can help.
The Insulin Dose Adjustment (IDA) feature will enable prescribing physicians using ALRT to compare a patient’s current prescribed insulin dose with the dose recommended by the American Academy of Clinical Endocrinologists and the American Diabetes Association given the patient’s weight, A1c level, and blood glucose readings. If the IDA algorithm sees a discrepancy it will suggest a dose adjustment to more closely conform to the AACE and ADA guidelines.
The IDA feature is currently being reviewed for clearance by the U.S. Food and Drug Administration (FDA) and not yet available in the United States.